Improvements in antenatal screening for Down's syndrome

نویسندگان

  • N J Wald
  • J P Bestwick
  • W J Huttly
چکیده

OBJECTIVES To estimate improvements to four antenatal screening tests for Down's syndrome (first trimester Combined, second trimester Quadruple, and first and second trimester Integrated and Serum Integrated tests) based on adding ductus venosus pulsatility index (DVPI), fetal nasal bone examination (NBE) and serum placental growth factor (PlGF). SETTING Statistical analysis of data from several sources modelled using the maternal age distribution of live births in England and Wales from 2006 to 2008. METHODS Monte Carlo simulation carried out to estimate the screening performance of tests with the addition of combinations of DVPI, NBE and PlGF. RESULTS At a 95% detection rate (DR), with first trimester markers measured at 11 completed weeks' gestation, the addition of DVPI, NBE and PlGF decreased the false-positive rate (FPR) of the Combined test from 16.1% to 3.0%, the addition of PlGF to the Quadruple test decreased the FPR from 15.7% to 15.3%, the addition of DVPI, NBE and PlGF to the Integrated test decreased the FPR from 4.1% to 0.6% and the addition of PlGF to the Serum Integrated test decreased the FPR from 15.1% to 11.1%. At a 90% detection rate, the reductions in the FPR were from 6.8% to 0.8%, 7.7% to 7.4%, 1.2% to 0.1% and 6.2% to 4.8%, respectively. CONCLUSIONS The addition of DVPI, NBE and PlGF to the Combined and Integrated tests significantly improves screening performance, reducing the FPRs by over 80%. The Integrated test with DVPI, NBE and PlGF is significantly better than the Combined test with DVPI, NBE and PlGF.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Trends in Down’s syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register

OBJECTIVES To describe trends in the numbers of Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008. Design and setting The National Down Syndrome Cytogenetic Register holds details of 26488 antenatal and postnatal diagnoses of Down's syndrome made by all cytogenetic laboratories in England and Wales since 1989. INTERVENTIONS Antenatal screening, diagnos...

متن کامل

Strategies for antenatal detection of Down's syndrome.

AIM To predict the effect of maternal serum screening and fetal echocardiography on the birth prevalence of Down's syndrome. METHODS The outcome of all Down's syndrome pregnancies in the Northern Health Region between 1985 and 1991 was retrospectively ascertained. The number and outcome of all Down's syndrome pregnancies were used to define a theoretical population which would exist in the ab...

متن کامل

Chronic constipation in long stay

syndrome. In: Grudzinskas JG, Chard T, Chapman M, Cuckle HS, eds. Cambridge: Cambridge University Press, 1993 (in press). 25 Laundon C, Spencer K, Macri JN, Buchanan P. Tumer syndrome detection by MSAFP/Free Beta (hCG) screening. J Med Genet 1993;30:340-1. 26 Spencer K, Mallard AS, Coombes EJ, Macri JN. Prenatal screening for trisomy 18 with free f3 human chorionic gonadotrophin. BMJ 1993 (in p...

متن کامل

Evaluation of a proposed mixture model to specify the distributions of nuchal translucency measurements in antenatal screening for Down's syndrome

OBJECTIVES A mixture model of crown-rump length (CRL)-dependent and CRL-independent nuchal translucency (NT) measurements has been proposed for antenatal screening for Down's syndrome. We here compare the efficacy of the mixture model method with the standard method, which uses NT multiple of the median (MoM) values in a single distribution. Settings A routine antenatal screening programme for ...

متن کامل

Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.

OBJECTIVES To assess the implementation of antenatal screening for Down's syndrome in practice, using individual risk estimates based on maternal age and the three serum markers: alpha fetoprotein, unconjugated oestriol, and human chorionic gonadotrophin. DESIGN Demonstration project of Down's syndrome screening; women with a risk estimate at term of 1 in 250 or greater were classified as "sc...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 20  شماره 

صفحات  -

تاریخ انتشار 2013